InvestorsHub Logo

TOB

Followers 162
Posts 5764
Boards Moderated 1
Alias Born 09/15/2010

TOB

Re: Pyrrhonian post# 14027

Friday, 06/20/2014 1:40:58 PM

Friday, June 20, 2014 1:40:58 PM

Post# of 718776
That the PR was hyped is an expert opinion which I accept.

How was it "hyped," sir?



"If you flip the coin and the trial results were negative, do you think the company would be disclosing this type of information? No, the company is trying to create tremendous hype about its product, which is very concerning to me as an academic oncologist," said Buzdar. [vice-president of clinical research at MD Anderson



I see the word "hype".

And

Jim Newman, a spokesman for M.D. Anderson, said Northwest Biotherapeutics had released bits and pieces of data from the ongoing trial in a series of recent press releases that had the potential to provide an inaccurate picture of results from the Phase I/II study. Link to MD Anderson PR



QED
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News